Assessment of Total, PTEN–, and AR-V7+ Circulating Tumor Cell Count by Flow Cytometry in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving EnzalutamideGiuseppe Di Lorenzo, Carlo Buonerba, Vincenzo Caputo et al.|Clinical Genitourinary Cancer|2021Cited by 23